Replies to post #2273 on Enanta Pharmaceuticals Inc (ENTA)

[DewDiligence]

Shionogi’s S-217622 has some issues:

#msg-168536263 teratogenicity
#msg-169462279 efficacy not proven

More info on S-217622 than you probably wanted to know:
https://www.biorxiv.org/content/10.1101/2022.01.26.477782v1.full